Clinical trial

Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients…

NCT00239057 · Novartis, Industry · Completed

Key facts

NCT number NCT00239057
Title Study of Enteric-coated Mycophenolate Sodium Maintenance Therapy in Patients With Renal Transplant Receiving Cyclosporine Microemulsion and Steroids,
Official title Enteric-Coated Mycophenolate Sodium (EC-MPS) Administration in Maintenance Renal Transplant Patients Receiving Cyclosporine Microemulsion (CsA-ME) and Steroids, for the Withdrawal of Concomitant Steroid Therapy: a Prospective, Open-label, Exploratory Study
Lead sponsor Novartis, Industry
Status Completed
Phase Phase 3
Study type Interventional
Conditions Maintenance Renal Transplantation
Intervention type Drug
Interventions Enteric-Coated Mycophenolate Sodium
Enrollment 23
Start date May 1, 2002
Primary completion Jan 1, 2005
Completion Jan 1, 2005
First posted Oct 14, 2005
Last update posted Jan 31, 2011

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies